Molecular epidemiology of HCV - Viral Hepatitis Prevention Board

More documents

Recommendations

Info

3. SEQUENCING 310 Genetic Analyzer 24/24 hours , 7/7 days capilar LÁSER ventana migración
ENDOSCOPY G1b X1BENO 235 1000 224 22 65 185 11 13 14 4 89 164 251 250 487 X1BKOR 1000 SR1bPR9 X1BOKA NR1bPR7 X1BXIN X1BAIZ NR1bRb2 NR1bPR1 X1BTAK NR1bNULL6 X1BAUST XAUS2 CHRONIC <strong>HCV</strong>+ ENDOSCOPY NR1bNULL2 SR1bRVR3 X1BGRM LC17 ACUTE INFECTED ENDOS CTA1 6 100 76 119 3 262 21 75 171 442 400 290 NR1bNULL7 NR1bNULL1 NR1bNULL5 SR1bPR4 989 SR1bRVR10 SR1bRVR21 X1BHON SR1bRVR5 LC14 LC18 LC19 SR1bPR8 GENETIC DISTANCE: CTA1-LC / CTA1-Genbank= 7.8-14.7% CTA- ENDOS = 12.4%
Page 1 and 2: MOLECULAR EPIDEMIOLOGY OF HCV
Page 3 and 4: QUASISPECIES NATURE OF HCV Mutant s
Page 5 and 6: RATE OF FIXATION OF MUTATIONS (muta
Page 7 and 8: TRANSMISSION MECHANISMS OF HCV A. P
Page 9: PHYLOGENETIC ANALYSIS GENETIC DISTA
Page 12 and 13: SEXUAL TRANSMISSION PATIENT August
Page 14 and 15: PHYLOGENETIC ANALYSIS. Consensus an
Page 16 and 17: NOSSOCOMIAL patient-to-patient TRAN
Page 18 and 19: A2- SOURCE OF INFECTION Department
Page 22 and 23: CTA patient, also underwent a Contr
Page 24 and 25: MULTI-DOSE CONTRAST MEDIUM EQUIPMEN

Molecular epidemiology of HCV - Viral Hepatitis Prevention Board

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?